Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
chlorhydrate d'isoprénaline 2 mg/2 mL, concentré pour perfusion |
Is a |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoprenaline adverse reaction |
Causative agent (attribute) |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Oral isoprenaline adverse reaction |
Causative agent (attribute) |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Inhaled isoprenaline adverse reaction |
Causative agent (attribute) |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Parenteral isoprenaline adverse reaction |
Causative agent (attribute) |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoprenaline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
|
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
1 |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoprenaline hydrochloride |
Inferred relationship |
Some |
1 |